INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 46h ago
HOUSE PTR6h ago
SEC 13F6h ago
ROBINHOOD CHAIN6h ago
SEC FORM 4/Open-market saleVerified dataRule 10b5-1 plan

DeSimone Jill sold PRAX

Director · Praxis Precision Medicines, Inc. · Common Stock

Side
SELL
Value
$544K
Shares
1,750
Price
$310.89
Executed
Jun 24, 2026
Disclosed
Jun 26, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jun 24 executedJun 26, 2026 disclosed

PRAX · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
15/ 100 · ROUTINE
Methodology →
  • Transaction type+6 / 20

    Open-market sale

  • Relative size+11 / 25

    $544K reported value · 16.6% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • Pre-arranged plan-10

    Executed under a Rule 10b5-1 trading plan

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · PRAX

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    20
    Gilbert Ray Cisneros, Jr.DSelf
    PRAXPraxis Precision Medicines, Inc.
    Purchase
    		BUY$1,001 – $15KSep 29, 2026Oct 12, 2026
    traded Sep 29, 2026
    		+13dHOUSE PTR

    Evidence

    28
    Gilbert Ray Cisneros, Jr.DSelf
    PRAXPraxis Precision Medicines, Inc.
    Purchase
    		BUY$1,001 – $15KJul 30, 2026Sep 4, 2026
    traded Jul 30, 2026
    		+36dHOUSE PTR

    Evidence

    0
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Option exercise · 10b5-1 plan
    		M—
    3,034 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    12
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$210K
    683 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    15
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$382K
    1,240 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    15
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$309K
    999 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    19
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$890K
    2,854 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    15
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$314K
    1,004 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    12
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$158K
    504 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    19
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$403K
    1,279 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    19
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$264K
    837 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    0
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Option exercise · 10b5-1 plan
    		M—
    8,566 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    17
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Option exercise · 10b5-1 plan
    		M$379K
    8,566 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    13
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Option exercise · 10b5-1 plan
    		M$447K
    3,034 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    5
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$3,014
    10 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    5
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$36K
    120 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    8
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$98K
    320 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    12
    ML
    Mastrocola LaurenPrincipal Accounting Officer
    PRAXPraxis Precision Medicines, Inc.
    Tax withholding
    		F$95K
    344 sh
    		Jan 12, 2026Jan 13, 2026
    traded Jan 12, 2026
    		+1dSEC FORM 4

    Evidence

    12
    NA
    Nemiroff AlexGeneral Counsel and Secretary
    PRAXPraxis Precision Medicines, Inc.
    Tax withholding
    		F$212K
    768 sh
    		Jan 12, 2026Jan 13, 2026
    traded Jan 12, 2026
    		+1dSEC FORM 4

    Evidence

    12
    SM
    Sniecinski MeganChief Operating Officer
    PRAXPraxis Precision Medicines, Inc.
    Tax withholding
    		F$244K
    885 sh
    		Jan 12, 2026Jan 13, 2026
    traded Jan 12, 2026
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001930479-26-000003
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Jun 24, 2026
    Published
    Jun 26, 2026
    Ingested by INSIDER
    Nov 5, 03:50 UTC
    Last re-read
    Nov 5, 03:50 UTC

    Extracted facts

    Filer
    DeSimone Jill
    Role
    Director
    Transaction
    Open-market saleAs filed: “S”
    Asset
    Praxis Precision Medicines, Inc.
    Ticker
    PRAX
    Shares
    1,750
    Price per share
    $310.89
    Value
    $544,056
    Execution date (reported)
    Jun 24, 2026
    Owned after transaction
    8,815 shares
    Rule 10b5-1 plan
    Yes, as checked by the filer
    Days from execution to publication
    2

    Calculation

    Value = shares × reported price per share

    • Shares: 1,750
    • Price: $310.889

    = $544,056

    What this establishes

    DeSimone Jill filed this Form 4 reporting a open-market sale of PRAX on Jun 24, 2026. It became public on Jun 26, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    DeSimone Jillcik:0001930479
    Issuer
    Praxis Precision Medicines, Inc.cik:0001689548

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.